Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
boston blog main
boston top stories
4
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
4
×
wisconsin top stories
biotech
celgene
deals
alnylam pharmaceuticals
biogen
biomarin pharmaceutical
cancer
drug prices
gene therapy
hemophilia
ipo
medicare
novartis
pfizer
What
bio
4
×
gene
4
×
roundup
drug
therapy
moves
patients
prices
advanced
alnylam’s
alzheimer’s
approval
aren’t
becker
bff
billions
companies
conference
deals
developers
devoted
different
disease
dollars
drugs
easl
eaton
fail
fda
form
healthcare
help
imminent
impact
increases
kicked
latest
life
liver
long
Language
Current search:
bio
×
photo
×
" boston top stories "
×
" san diego top stories "
×
" wisconsin blog main "
×
gene
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More